Bio-Techne releases new T-cell activation kit

By The Science Advisory Board staff writers

May 11, 2020 -- Bio-Techne has released a new kit for cell and gene therapy manufacturing called GMP Cloudz Human T Cell Activation.

The kit is the first in the company's Cloudz product line. It contains Cloudz particles, which are dissolvable microspheres designed for CD3 and CD28 antibodies for the expansion of T cells, the company said. The kit works within the company's T cell culture platform. The particles can be added to CD3+ T cells or peripheral blood mononuclear cells (PBMC), according to Bio-Techne.

Joint venture targets cell and gene therapy
A new joint venture dedicated to supporting researchers and biopharmaceutical companies in cell and gene therapy was announced on January 21. The joint...
Overlooked benefits of using polyclonal antibodies
The benefits of polyclonal antibodies as tools for assay-specific target discovery and detection are numerous. As the future of basic research, diagnostics...

Copyright © 2020

Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter